C.M. Bidwell & Associates’s Signify Health, Inc. SGFY Stock Holding History

C.M. Bidwell & Associates’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82	Closed	-$2.35K	–	577
2022 Q4	$2.35K	Hold	82	–	–	﹤0.01%	432
2022 Q3	$2K	Hold	82	–	–	﹤0.01%	444
2022 Q2	$1K	Hold	82	–	–	﹤0.01%	484
2022 Q1	$1K	Buy	+82	New	+$1.18K	﹤0.01%	525

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

C.M. Bidwell & Associates's SGFY Position: Q1 2023 in Review

C.M. Bidwell & Associates sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 82 shares — an estimated $2.35K sold.

C.M. Bidwell & Associates first reported a position in SGFY in Q1 2022 and held it in 4 quarters. The position peaked at $2.35K in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

C.M. Bidwell & Associates reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
C.M. Bidwell & Associates sold 82 Signify Health, Inc. shares in Q1 2023, an estimated $2.35K.
C.M. Bidwell & Associates first reported a position in Signify Health, Inc. in Q1 2022 and held it in 4 quarters.
C.M. Bidwell & Associates's Signify Health, Inc. position peaked at $2.35K in Q4 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.